You are here

VLA15

Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster

Clinical Trials Arena

Tue, 09/3/24 - 11:25 am

clinical trials

Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response

Fierce Biotech

Thu, 09/7/23 - 09:37 am

clinical trials

Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025

Seeking Alpha

Sun, 03/26/23 - 11:12 pm

clinical trials

Pfizer, Valneva remove half of participants from study of Lyme disease shot

BioPharma Dive

Fri, 02/17/23 - 11:27 am

clinical trials

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

BioSpace

Tue, 08/9/22 - 06:27 am

clinical trials

Valneva and Pfizer report positive Phase 2 data for Lyme disease vaccine in children

Biopharma Reporter

Tue, 04/26/22 - 10:27 am

clinical trials

Pfizer's $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies

Fierce Biotech

Fri, 02/4/22 - 11:06 am

clinical trials

Valneva, hit by COVID contract chaos, sees Lyme disease vaccine drop-off in phase 2, but boosters helping

Fierce Biotech

Tue, 09/28/21 - 11:08 am

clinical trials

Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate

Biopharma Reporter

Mon, 03/8/21 - 09:14 pm

clinical trials

Can a new Lyme disease vaccine overcome a history of distrust and failure?

Stat

Fri, 08/23/19 - 10:13 am

drug development